![]() ![]() | Moes, B., Li, H., Molina Ortiz, P., Radermecker, C., Rosu, A., Vande Catsyne, C.-A., Sayyed, S. A., Fontela Joao, Duque, M., Mostafa, A., Azzi, A., Barata Joao T., Merino Ramon, Xu, C., Desmet, C., & Schurmans, S. (2023). INPP5K controls the dynamic structure and signaling of wild type and mutated, leukemia-associated IL7 receptors. Blood, 141, 1708-1717. doi:10.1182/blood.2022017819 ![]() |
![]() ![]() | Vande Catsyne, C.-A., Sayyed, S. A., Molina Ortiz, P., Moës, B., Communi, D., Muller, J., Heusschen, R., CAERS, J., Azzi, A., Erneux, C., & Schurmans, S. (2020). Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia. Advances in Biological Regulation, 76, 100651. doi:10.1016/j.jbior.2019.100651 ![]() |
![]() ![]() | Sayyed, S. A., JOURET, F., Vermeersch, M., Pérez-Morga, D., & Schurmans, S. (2017). The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating ERM proteins activation. Kidney International. doi:10.1016/j.kint.2017.01.008 ![]() |
![]() ![]() | Sayyed, S. A., Grosse, C., Steiger, K., & Heid, I. (2015). Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-14-2018 ![]() |
![]() ![]() | Schurmans, S., Polizzi, S., Scoumanne, A., Sayyed, S. A., & Molina Ortiz, P. (2015). The Ras/Rap GTPase activating protein RASA3 : from gene structure to in vivo functions. Advances in Biological Regulation, 57, 153-161. doi:10.1016/j.jbior.2014.09.006 ![]() |
![]() ![]() | Sayyed, S. A. (2011). Oral treatment with a chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney International, 80 (1), 68. ![]() |
![]() ![]() | Sayyed, S. A. (2011). Dual blockade of the homeostatic chemokine CXCL12 and the pro-inflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. American Journal of Cardiology, 179 (1), 116. ![]() |
![]() ![]() | Sayyed, S. A. (2011). Mdm2 promotes systemic lupus erythematosus and lupus nephritis. Journal of the American Society of Nephrology, 22 (11), 2016. doi:10.1681/ASN.2011010045 ![]() |
![]() ![]() | Sayyed, S. A. (2010). Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrology Dialysis Transplantation, 25 (6), 1811. doi:10.1093/ndt/gfp730 ![]() |
![]() ![]() | Sayyed, S. A. (2010). Podocytes express the homeostatic chemokine stromal cell-derived factor-1/CXCL12 which contributes to glomerulosclerosis, podocyte loss, and albuminuria in type 2 diabetes. Diabetologia, 52 (11), 2445. ![]() |
![]() ![]() | Sayyed, S. A. (2010). 4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses Systemic Lupus Erythematosus in MRL-(Fas)lpr Mice. American Journal of Pathology, 176 (6), 2840. doi:10.2353/ajpath.2010.091227 ![]() |
![]() ![]() | Sayyed, S. A. (2010). Renal failure increases cardiac histone H3K9 and H3K23 acetylation, H3K4 dimethylation, phosphorylation at serine 10 and reduces the H3K9 dimethylation in type 2 diabetes. American Journal of Pathology, 176 (3), 1079. ![]() |
![]() ![]() | Sayyed, S. A. (2009). Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in rat. Metabolism: Clinical and Experimental, 58 (3), 333. doi:10.1016/j.metabol.2008.10.005 ![]() |
![]() ![]() | Sayyed, S. A. (2009). Questions about Chemokine and Chemokine Receptor Antagonism in Renal Inflammation. Nephron. Experimental Nephrology, 14 (2), 33. ![]() |
![]() ![]() | Sayyed, S. A. (2009). 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice. Metabolism: Clinical and Experimental, 58 (10), 1503. doi:10.1016/j.metabol.2009.04.036 ![]() |
![]() ![]() | Sayyed, S. A. (2006). Trolox ameliorates the nerve conduction velocity, nerve blood flow and nociception deficits in experimental diabetic neuropathy. Clinical and Experimental Pharmacology and Physiology. Supplement, 33 (11), 1022. ![]() |
![]() ![]() | Sayyed, S. A. (2006). Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sciences, 79 (8), 777. doi:10.1016/j.lfs.2006.02.033 ![]() |